Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHC Bausch Health Companies	$6.49 +0.1%	$7.07	$3.96 ▼ $11.46	$2.39B	0.59	2.76 million shs	1.29 million shs
ELAN Elanco Animal Health	$10.47 +0.6%	$11.23	$10.03 ▼ $18.80	$5.18B	1.44	4.78 million shs	1.89 million shs
ZTS Zoetis	$164.55 +0.9%	$166.40	$144.80 ▼ $200.33	$73.56B	0.94	2.59 million shs	1.29 million shs

The 10 Best Stocks to Own: Spring 2025

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHC Bausch Health Companies	0.00%	-9.49%	-12.78%	-16.11%	-38.88%
ELAN Elanco Animal Health	0.00%	-1.49%	-7.06%	-12.06%	-36.15%
ZTS Zoetis	0.00%	+0.10%	-2.72%	+0.49%	-3.65%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BHC Bausch Health Companies	3.9547 of 5 stars	1.9	5.0	0.0	4.0	1.8	1.7	1.9
ELAN Elanco Animal Health	4.0775 of 5 stars	4.2	3.0	0.0	0.3	2.3	3.3	0.6
ZTS Zoetis	4.595 of 5 stars	3.5	3.0	4.2	0.4	3.6	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BHC Bausch Health Companies	1.86	Reduce	$7.42	14.37% Upside
ELAN Elanco Animal Health	2.43	Hold	$15.17	44.83% Upside
ZTS Zoetis	3.08	Buy	$215.90	31.21% Upside

Current Analyst Ratings Breakdown

Latest ZTS, BHC, and ELAN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/6/2025	ELAN Elanco Animal Health	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$16.00 ➝ $12.00
2/27/2025	ZTS Zoetis	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$200.00 ➝ $205.00
2/26/2025	ELAN Elanco Animal Health	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$18.00 ➝ $17.00
2/26/2025	ELAN Elanco Animal Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$14.00 ➝ $13.00
2/26/2025	ELAN Elanco Animal Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$20.00 ➝ $19.00
2/21/2025	ELAN Elanco Animal Health	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$18.00 ➝ $16.00
2/14/2025	ZTS Zoetis	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$242.00 ➝ $244.00
2/14/2025	ZTS Zoetis	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$243.00 ➝ $238.00
2/10/2025	ZTS Zoetis	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$210.00 ➝ $200.00
2/6/2025	BHC Bausch Health Companies	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$12.00 ➝ $8.00
2/4/2025	ZTS Zoetis	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$243.00

(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BHC Bausch Health Companies	$9.63B	0.25	$6.90 per share	0.94	($0.89) per share	-7.29
ELAN Elanco Animal Health	$4.44B	1.17	$2.16 per share	4.84	$12.63 per share	0.83
ZTS Zoetis	$9.26B	7.96	$7.39 per share	22.26	$10.65 per share	15.45

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BHC Bausch Health Companies	-$46M	-$0.12	N/A	1.39	0.37	-0.48%	-577.82%	5.24%	4/30/2025 (Estimated)
ELAN Elanco Animal Health	-$1.23B	$0.67	26.19	11.77	2.50	4.60%	6.78%	3.03%	5/6/2025 (Estimated)
ZTS Zoetis	$2.49B	$5.47	30.03	24.38	2.78	26.86%	53.82%	18.86%	5/6/2025 (Estimated)

Latest ZTS, BHC, and ELAN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
2/25/2025	Q4 2024	ELAN Elanco Animal Health	$0.15	$0.14	-$0.01	-$0.02	$1.01 billion	$1.02 billion
2/19/2025	Q4 2024	BHC Bausch Health Companies	$1.65	$1.21	-$0.44	$0.25	$2.51 billion	$2.56 billion
2/13/2025	Q4 2024	ZTS Zoetis	$1.37	$1.40	+$0.03	$1.29	$2.30 billion	$2.32 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BHC Bausch Health Companies	N/A	N/A	N/A	N/A	N/A
ELAN Elanco Animal Health	N/A	N/A	N/A	N/A	N/A
ZTS Zoetis	$2.00	1.22%	+18.66%	36.56%	14 Years

Latest ZTS, BHC, and ELAN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/6/2025	ZTS Zoetis	quarterly	$0.50	1.2%	4/21/2025	4/21/2025	6/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BHC Bausch Health Companies	N/A	0.86	0.62
ELAN Elanco Animal Health	0.66	2.55	1.31
ZTS Zoetis	1.09	1.75	1.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BHC Bausch Health Companies	78.65%
ELAN Elanco Animal Health	97.48%
ZTS Zoetis	92.80%

Insider Ownership

Company	Insider Ownership
BHC Bausch Health Companies	8.12%
ELAN Elanco Animal Health	0.57%
ZTS Zoetis	0.16%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BHC Bausch Health Companies	19,900	367.93 million	338.06 million	Optionable
ELAN Elanco Animal Health	9,800	494.61 million	491.54 million	Optionable
ZTS Zoetis	14,100	447.79 million	447.08 million	Optionable

ZTS, BHC, and ELAN Headlines

Recent News About These Companies

Zoetis Inc. (NYSE:ZTS) Shares Sold by Clearbridge Investments LLC

March 31 at 7:20 AM | marketbeat.com

CIBC Private Wealth Group LLC Decreases Stock Holdings in Zoetis Inc. (NYSE:ZTS)

March 31 at 6:41 AM | marketbeat.com

Martin Currie Ltd. Reduces Stock Holdings in Zoetis Inc. (NYSE:ZTS)

March 31 at 6:39 AM | marketbeat.com

Allstate Corp Invests $2.19 Million in Zoetis Inc. (NYSE:ZTS)

March 31 at 5:11 AM | marketbeat.com

DnB Asset Management AS Raises Position in Zoetis Inc. (NYSE:ZTS)

March 31 at 5:02 AM | marketbeat.com

Rep. Robert Bresnahan, Jr. Sells Zoetis Inc. (NYSE:ZTS) Stock

March 30 at 8:03 AM | marketbeat.com

State Farm Mutual Automobile Insurance Co. Sells 26,093 Shares of Zoetis Inc. (NYSE:ZTS)

March 30 at 6:58 AM | marketbeat.com

Brown Brothers Harriman & Co. Decreases Stock Holdings in Zoetis Inc. (NYSE:ZTS)

March 30 at 6:13 AM | marketbeat.com

Orion Portfolio Solutions LLC Buys 5,447 Shares of Zoetis Inc. (NYSE:ZTS)

March 30 at 5:53 AM | marketbeat.com

New Age Alpha Advisors LLC Purchases Shares of 24,838 Zoetis Inc. (NYSE:ZTS)

March 30 at 5:35 AM | marketbeat.com

UniSuper Management Pty Ltd Has $5.08 Million Stake in Zoetis Inc. (NYSE:ZTS)

March 30 at 5:10 AM | marketbeat.com

Zoetis Inc. (NYSE:ZTS) Receives Consensus Recommendation of "Buy" from Brokerages

March 30 at 2:19 AM | marketbeat.com

Alerus Financial NA Lowers Position in Zoetis Inc. (NYSE:ZTS)

March 29 at 7:11 AM | marketbeat.com

denkapparat Operations GmbH Invests $373,000 in Zoetis Inc. (NYSE:ZTS)

March 29 at 6:57 AM | marketbeat.com

Pictet Asset Management Holding SA Acquires 455,191 Shares of Zoetis Inc. (NYSE:ZTS)

March 29 at 6:48 AM | marketbeat.com

Broadway Wealth Solutions Inc. Takes $273,000 Position in Zoetis Inc. (NYSE:ZTS)

March 29 at 6:40 AM | marketbeat.com

Norges Bank Invests $824.32 Million in Zoetis Inc. (NYSE:ZTS)

March 29 at 6:05 AM | marketbeat.com

Caisse Des Depots ET Consignations Makes New $311,000 Investment in Zoetis Inc. (NYSE:ZTS)

March 29 at 6:05 AM | marketbeat.com

NEOS Investment Management LLC Increases Stock Holdings in Zoetis Inc. (NYSE:ZTS)

March 29 at 5:38 AM | marketbeat.com

Zoetis Inc. (NYSE:ZTS) Shares Sold by Elo Mutual Pension Insurance Co

March 29 at 5:29 AM | marketbeat.com

Zoetis (ZTS) Stock Moves -1.16%: What You Should Know

March 28 at 9:49 PM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZTS, BHC, and ELAN Company Descriptions

Bausch Health Companies NYSE:BHC

$6.48 +0.01 (+0.08%)

As of 03:58 PM Eastern

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Elanco Animal Health NYSE:ELAN

$10.47 +0.06 (+0.60%)

As of 03:58 PM Eastern

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Zoetis NYSE:ZTS

$164.55 +1.44 (+0.88%)

As of 03:58 PM Eastern

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time